Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 241 to 251 of 251 entries
Sorted by: Best Match Show Resources per page
Update on radionuclide therapy in oncology.

Oncology letters

Nitipir C, Niculae D, Orlov C, Barbu MA, Popescu B, Popa AM, Pantea AMS, Stanciu AE, Galateanu B, Ginghina O, Papadakis GZ, Izotov BN, Spandidos DA, Tsatsakis AM, Negrei C.
PMID: 29344129
Oncol Lett. 2017 Dec;14(6):7011-7015. doi: 10.3892/ol.2017.7141. Epub 2017 Oct 05.

Unstable isotopes and their capacity to emit ionizing radiation have been employed in clinical practice not only for diagnostic, but also for therapeutic purposes, with significant contribution in several fields of medicine and primarily in the management of oncologic...

Cite
Nitipir C, Niculae D, Orlov C, et al. Update on radionuclide therapy in oncology. Oncol Lett. 2017;14(6):7011-7015doi: 10.3892/ol.2017.7141.
Nitipir, C., Niculae, D., Orlov, C., Barbu, M. A., Popescu, B., Popa, A. M., Pantea, A. M. S., Stanciu, A. E., Galateanu, B., Ginghina, O., Papadakis, G. Z., Izotov, B. N., Spandidos, D. A., Tsatsakis, A. M., & Negrei, C. (2017). Update on radionuclide therapy in oncology. Oncology letters, 14(6), 7011-7015. https://doi.org/10.3892/ol.2017.7141
Nitipir, Cornelia, et al. "Update on radionuclide therapy in oncology." Oncology letters vol. 14,6 (2017): 7011-7015. doi: https://doi.org/10.3892/ol.2017.7141
Nitipir C, Niculae D, Orlov C, Barbu MA, Popescu B, Popa AM, Pantea AMS, Stanciu AE, Galateanu B, Ginghina O, Papadakis GZ, Izotov BN, Spandidos DA, Tsatsakis AM, Negrei C. Update on radionuclide therapy in oncology. Oncol Lett. 2017 Dec;14(6):7011-7015. doi: 10.3892/ol.2017.7141. Epub 2017 Oct 05. PMID: 29344129; PMCID: PMC5754838.
Copy Download .nbib Format: NLM
Sustained Release from Injectable Composite Gels Loaded with Silver Nanowires Designed to Combat Bacterial Resistance in Bone Regeneration Applications.

Pharmaceutics

De Mori A, Hafidh M, Mele N, Yusuf R, Cerri G, Gavini E, Tozzi G, Barbu E, Conconi M, Draheim RR, Roldo M.
PMID: 30871056
Pharmaceutics. 2019 Mar 12;11(3). doi: 10.3390/pharmaceutics11030116.

One-dimensional nanostructures, such as silver nanowires (AgNWs), have attracted considerable attention owing to their outstanding electrical, thermal and antimicrobial properties. However, their application in the prevention of infections linked to bone tissue regeneration intervention has not yet been explored....

Cite
De Mori A, Hafidh M, Mele N, et al. Sustained Release from Injectable Composite Gels Loaded with Silver Nanowires Designed to Combat Bacterial Resistance in Bone Regeneration Applications. Pharmaceutics. 2019;11(3)doi: 10.3390/pharmaceutics11030116.
De Mori, A., Hafidh, M., Mele, N., Yusuf, R., Cerri, G., Gavini, E., Tozzi, G., Barbu, E., Conconi, M., Draheim, R. R., & Roldo, M. (2019). Sustained Release from Injectable Composite Gels Loaded with Silver Nanowires Designed to Combat Bacterial Resistance in Bone Regeneration Applications. Pharmaceutics, 11(3), . https://doi.org/10.3390/pharmaceutics11030116
De Mori, Arianna, et al. "Sustained Release from Injectable Composite Gels Loaded with Silver Nanowires Designed to Combat Bacterial Resistance in Bone Regeneration Applications." Pharmaceutics vol. 11,3 (2019). doi: https://doi.org/10.3390/pharmaceutics11030116
De Mori A, Hafidh M, Mele N, Yusuf R, Cerri G, Gavini E, Tozzi G, Barbu E, Conconi M, Draheim RR, Roldo M. Sustained Release from Injectable Composite Gels Loaded with Silver Nanowires Designed to Combat Bacterial Resistance in Bone Regeneration Applications. Pharmaceutics. 2019 Mar 12;11(3). doi: 10.3390/pharmaceutics11030116. PMID: 30871056; PMCID: PMC6471462.
Copy Download .nbib Format: NLM
Pharmacological treatment of hyperactive delirium in people with COVID-19: rethinking conventional approaches.

Therapeutic advances in psychopharmacology

Ostuzzi G, Gastaldon C, Papola D, Fagiolini A, Dursun S, Taylor D, Correll CU, Barbui C.
PMID: 32733668
Ther Adv Psychopharmacol. 2020 Jul 20;10:2045125320942703. doi: 10.1177/2045125320942703. eCollection 2020.

People with coronavirus disease (COVID-19) might have several risk factors for delirium, which could in turn notably worsen the prognosis. Although pharmacological approaches for delirium are debated, haloperidol and other first-generation antipsychotics are frequently employed, particularly for hyperactive presentations....

Cite
Ostuzzi G, Gastaldon C, Papola D, et al. Pharmacological treatment of hyperactive delirium in people with COVID-19: rethinking conventional approaches. Ther Adv Psychopharmacol. 2020;10:2045125320942703doi: 10.1177/2045125320942703.
Ostuzzi, G., Gastaldon, C., Papola, D., Fagiolini, A., Dursun, S., Taylor, D., Correll, C. U., & Barbui, C. (2020). Pharmacological treatment of hyperactive delirium in people with COVID-19: rethinking conventional approaches. Therapeutic advances in psychopharmacology, 102045125320942703. https://doi.org/10.1177/2045125320942703
Ostuzzi, Giovanni, et al. "Pharmacological treatment of hyperactive delirium in people with COVID-19: rethinking conventional approaches." Therapeutic advances in psychopharmacology vol. 10 (2020): 2045125320942703. doi: https://doi.org/10.1177/2045125320942703
Ostuzzi G, Gastaldon C, Papola D, Fagiolini A, Dursun S, Taylor D, Correll CU, Barbui C. Pharmacological treatment of hyperactive delirium in people with COVID-19: rethinking conventional approaches. Ther Adv Psychopharmacol. 2020 Jul 20;10:2045125320942703. doi: 10.1177/2045125320942703. eCollection 2020. PMID: 32733668; PMCID: PMC7372613.
Copy Download .nbib Format: NLM
Hemiplegic Migraine Associated With .

Neurology

Riant F, Roos C, Roubertie A, Barbance C, Hadjadj J, Auvin S, Baille G, Beltramone M, Boulanger C, Cahn A, Cata F, Cheuret E, Cuvellier JC, Defo A, Demarquay G, Donnet A, Gaillard N, Massardier E, Guy N, Lamoureux S, Le Moigno L, Lucas C, Ratiu D, Redon S, Rey C, Thauvin C, Viallet F, Tournier-Lasserve E, Ducros A.
PMID: 34649875
Neurology. 2022 Jan 04;98(1):e51-e61. doi: 10.1212/WNL.0000000000012947. Epub 2021 Oct 14.

No abstract available.

Cite
Riant F, Roos C, Roubertie A, et al. Hemiplegic Migraine Associated With . Neurology. 2021;98(1):e51-e61doi: 10.1212/WNL.0000000000012947.
Riant, F., Roos, C., Roubertie, A., Barbance, C., Hadjadj, J., Auvin, S., Baille, G., Beltramone, M., Boulanger, C., Cahn, A., Cata, F., Cheuret, E., Cuvellier, J. C., Defo, A., Demarquay, G., Donnet, A., Gaillard, N., Massardier, E., Guy, N., Lamoureux, S., Le Moigno, L., Lucas, C., Ratiu, D., Redon, S., Rey, C., Thauvin, C., Viallet, F., Tournier-Lasserve, E., & Ducros, A. (2022). Hemiplegic Migraine Associated With . Neurology, 98(1), e51-e61. https://doi.org/10.1212/WNL.0000000000012947
Riant, Florence, et al. "Hemiplegic Migraine Associated With ." Neurology vol. 98,1 (2022): e51-e61. doi: https://doi.org/10.1212/WNL.0000000000012947
Riant F, Roos C, Roubertie A, Barbance C, Hadjadj J, Auvin S, Baille G, Beltramone M, Boulanger C, Cahn A, Cata F, Cheuret E, Cuvellier JC, Defo A, Demarquay G, Donnet A, Gaillard N, Massardier E, Guy N, Lamoureux S, Le Moigno L, Lucas C, Ratiu D, Redon S, Rey C, Thauvin C, Viallet F, Tournier-Lasserve E, Ducros A. Hemiplegic Migraine Associated With . Neurology. 2022 Jan 04;98(1):e51-e61. doi: 10.1212/WNL.0000000000012947. Epub 2021 Oct 14. PMID: 34649875.
Copy Download .nbib Format: NLM
Polycystic ovary syndrome and postpartum depression: a systematic review and meta-analysis of observational studies.

Journal of affective disorders

Schoretsanitis G, Gastaldon C, Kalaitzopoulos DR, Ochsenbein-Koelble N, Barbui C, Seifritz E.
PMID: 34952106
J Affect Disord. 2021 Dec 21; doi: 10.1016/j.jad.2021.12.044. Epub 2021 Dec 21.

OBJECTIVE: To estimate the risk of postpartum depression (PPD) in women with polycystic ovary syndrome (PCOS) and assess related moderators.METHODS: Observational studies reporting on PPD rates in women with vs. without PCOS were identified in Embase/Medline/PsychInfo/Cinhail in 03/2021 since...

Cite
Schoretsanitis G, Gastaldon C, Kalaitzopoulos DR, et al. Polycystic ovary syndrome and postpartum depression: a systematic review and meta-analysis of observational studies. J Affect Disord. 2021;doi: 10.1016/j.jad.2021.12.044.
Schoretsanitis, G., Gastaldon, C., Kalaitzopoulos, D. R., Ochsenbein-Koelble, N., Barbui, C., & Seifritz, E. (2021). Polycystic ovary syndrome and postpartum depression: a systematic review and meta-analysis of observational studies. Journal of affective disorders, . https://doi.org/10.1016/j.jad.2021.12.044
Schoretsanitis, Georgios, et al. "Polycystic ovary syndrome and postpartum depression: a systematic review and meta-analysis of observational studies." Journal of affective disorders vol. (2021). doi: https://doi.org/10.1016/j.jad.2021.12.044
Schoretsanitis G, Gastaldon C, Kalaitzopoulos DR, Ochsenbein-Koelble N, Barbui C, Seifritz E. Polycystic ovary syndrome and postpartum depression: a systematic review and meta-analysis of observational studies. J Affect Disord. 2021 Dec 21; doi: 10.1016/j.jad.2021.12.044. Epub 2021 Dec 21. PMID: 34952106.
Copy Download .nbib Format: NLM
Towards the rational design of ylide-substituted phosphines for gold(i)-catalysis: from inactive to ppm-level catalysis.

Chemical science

Handelmann J, Babu CN, Steinert H, Schwarz C, Scherpf T, Kroll A, Gessner VH.
PMID: 34168748
Chem Sci. 2021 Feb 02;12(12):4329-4337. doi: 10.1039/d1sc00105a.

The implementation of gold catalysis into large-scale processes suffers from the fact that most reactions still require high catalyst loadings to achieve efficient catalysis thus making upscaling impractical. Here, we report systematic studies on the impact of the substituent...

Cite
Handelmann J, Babu CN, Steinert H, et al. Towards the rational design of ylide-substituted phosphines for gold(i)-catalysis: from inactive to ppm-level catalysis. Chem Sci. 2021;12(12):4329-4337doi: 10.1039/d1sc00105a.
Handelmann, J., Babu, C. N., Steinert, H., Schwarz, C., Scherpf, T., Kroll, A., & Gessner, V. H. (2021). Towards the rational design of ylide-substituted phosphines for gold(i)-catalysis: from inactive to ppm-level catalysis. Chemical science, 12(12), 4329-4337. https://doi.org/10.1039/d1sc00105a
Handelmann, Jens, et al. "Towards the rational design of ylide-substituted phosphines for gold(i)-catalysis: from inactive to ppm-level catalysis." Chemical science vol. 12,12 (2021): 4329-4337. doi: https://doi.org/10.1039/d1sc00105a
Handelmann J, Babu CN, Steinert H, Schwarz C, Scherpf T, Kroll A, Gessner VH. Towards the rational design of ylide-substituted phosphines for gold(i)-catalysis: from inactive to ppm-level catalysis. Chem Sci. 2021 Feb 02;12(12):4329-4337. doi: 10.1039/d1sc00105a. PMID: 34168748; PMCID: PMC8179644.
Copy Download .nbib Format: NLM
The relationship between pre-existing diabetes mellitus and the severity of acute pancreatitis: Report from a large international registry.

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]

Paragomi P, Papachristou GI, Jeong K, Hinton A, Pothoulakis I, Talukdar R, Kochhar R, Goenka MK, Gulla A, Gonzalez JA, Singh VK, Ferreira Bogado M, Stevens T, Barbu ST, Nawaz H, Gutierrez SC, Zarnescu N, Archibugi L, Easler JJ, Triantafyllou K, Peláez-Luna M, Thakkar S, Ocampo C, de-Madaria E, Cote GA, Wu BU, Lee PJ, Hart PA, Conwell DL, Toledo FGS, Yadav D.
PMID: 34656431
Pancreatology. 2022 Jan;22(1):85-91. doi: 10.1016/j.pan.2021.10.001. Epub 2021 Oct 10.

BACKGROUND/OBJECTIVES: The relationship between pre-existing diabetes mellitus (DM) and acute pancreatitis (AP) severity has not been established. We assessed the impact of pre-existing DM on AP severity in an international, prospectively ascertained registry.METHODS: APPRENTICE registry prospectively enrolled 1543 AP...

Cite
Paragomi P, Papachristou GI, Jeong K, et al. The relationship between pre-existing diabetes mellitus and the severity of acute pancreatitis: Report from a large international registry. Pancreatology. 2021;22(1):85-91doi: 10.1016/j.pan.2021.10.001.
Paragomi, P., Papachristou, G. I., Jeong, K., Hinton, A., Pothoulakis, I., Talukdar, R., Kochhar, R., Goenka, M. K., Gulla, A., Gonzalez, J. A., Singh, V. K., Ferreira Bogado, M., Stevens, T., Barbu, S. T., Nawaz, H., Gutierrez, S. C., Zarnescu, N., Archibugi, L., Easler, J. J., Triantafyllou, K., Peláez-Luna, M., Thakkar, S., Ocampo, C., de-Madaria, E., Cote, G. A., Wu, B. U., Lee, P. J., Hart, P. A., Conwell, D. L., Toledo, F. G. S., & Yadav, D. (2022). The relationship between pre-existing diabetes mellitus and the severity of acute pancreatitis: Report from a large international registry. Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 22(1), 85-91. https://doi.org/10.1016/j.pan.2021.10.001
Paragomi, Pedram, et al. "The relationship between pre-existing diabetes mellitus and the severity of acute pancreatitis: Report from a large international registry." Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] vol. 22,1 (2022): 85-91. doi: https://doi.org/10.1016/j.pan.2021.10.001
Paragomi P, Papachristou GI, Jeong K, Hinton A, Pothoulakis I, Talukdar R, Kochhar R, Goenka MK, Gulla A, Gonzalez JA, Singh VK, Ferreira Bogado M, Stevens T, Barbu ST, Nawaz H, Gutierrez SC, Zarnescu N, Archibugi L, Easler JJ, Triantafyllou K, Peláez-Luna M, Thakkar S, Ocampo C, de-Madaria E, Cote GA, Wu BU, Lee PJ, Hart PA, Conwell DL, Toledo FGS, Yadav D. The relationship between pre-existing diabetes mellitus and the severity of acute pancreatitis: Report from a large international registry. Pancreatology. 2022 Jan;22(1):85-91. doi: 10.1016/j.pan.2021.10.001. Epub 2021 Oct 10. PMID: 34656431.
Copy Download .nbib Format: NLM
The relationship between pre-existing diabetes mellitus and the severity of acute pancreatitis: Report from a large international registry.

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]

Paragomi P, Papachristou GI, Jeong K, Hinton A, Pothoulakis I, Talukdar R, Kochhar R, Goenka MK, Gulla A, Gonzalez JA, Singh VK, Ferreira Bogado M, Stevens T, Barbu ST, Nawaz H, Gutierrez SC, Zarnescu N, Archibugi L, Easler JJ, Triantafyllou K, Peláez-Luna M, Thakkar S, Ocampo C, de-Madaria E, Cote GA, Wu BU, Lee PJ, Hart PA, Conwell DL, Toledo FGS, Yadav D.
PMID: 34656431
Pancreatology. 2022 Jan;22(1):85-91. doi: 10.1016/j.pan.2021.10.001. Epub 2021 Oct 10.

BACKGROUND/OBJECTIVES: The relationship between pre-existing diabetes mellitus (DM) and acute pancreatitis (AP) severity has not been established. We assessed the impact of pre-existing DM on AP severity in an international, prospectively ascertained registry.METHODS: APPRENTICE registry prospectively enrolled 1543 AP...

Cite
Paragomi P, Papachristou GI, Jeong K, et al. The relationship between pre-existing diabetes mellitus and the severity of acute pancreatitis: Report from a large international registry. Pancreatology. 2021;22(1):85-91doi: 10.1016/j.pan.2021.10.001.
Paragomi, P., Papachristou, G. I., Jeong, K., Hinton, A., Pothoulakis, I., Talukdar, R., Kochhar, R., Goenka, M. K., Gulla, A., Gonzalez, J. A., Singh, V. K., Ferreira Bogado, M., Stevens, T., Barbu, S. T., Nawaz, H., Gutierrez, S. C., Zarnescu, N., Archibugi, L., Easler, J. J., Triantafyllou, K., Peláez-Luna, M., Thakkar, S., Ocampo, C., de-Madaria, E., Cote, G. A., Wu, B. U., Lee, P. J., Hart, P. A., Conwell, D. L., Toledo, F. G. S., & Yadav, D. (2022). The relationship between pre-existing diabetes mellitus and the severity of acute pancreatitis: Report from a large international registry. Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 22(1), 85-91. https://doi.org/10.1016/j.pan.2021.10.001
Paragomi, Pedram, et al. "The relationship between pre-existing diabetes mellitus and the severity of acute pancreatitis: Report from a large international registry." Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] vol. 22,1 (2022): 85-91. doi: https://doi.org/10.1016/j.pan.2021.10.001
Paragomi P, Papachristou GI, Jeong K, Hinton A, Pothoulakis I, Talukdar R, Kochhar R, Goenka MK, Gulla A, Gonzalez JA, Singh VK, Ferreira Bogado M, Stevens T, Barbu ST, Nawaz H, Gutierrez SC, Zarnescu N, Archibugi L, Easler JJ, Triantafyllou K, Peláez-Luna M, Thakkar S, Ocampo C, de-Madaria E, Cote GA, Wu BU, Lee PJ, Hart PA, Conwell DL, Toledo FGS, Yadav D. The relationship between pre-existing diabetes mellitus and the severity of acute pancreatitis: Report from a large international registry. Pancreatology. 2022 Jan;22(1):85-91. doi: 10.1016/j.pan.2021.10.001. Epub 2021 Oct 10. PMID: 34656431.
Copy Download .nbib Format: NLM
Lean mass, magnesium, faecal calprotectin and glucocorticoid exposure as risk factors for low bone mineral density in inflammatory bowel disease patients.

Endocrine connections

Soare I, Sirbu A, Diculescu MM, Mateescu BR, Tieranu C, Martin S, Barbu CG, Ionescu M, Fica S.
PMID: 34261042
Endocr Connect. 2021 Aug 09;10(8):918-925. doi: 10.1530/EC-21-0138.

BACKGROUND AND AIM: Low bone mineral density (BMD) is a common complication in patients with inflammatory bowel disease (IBD). However, debates are ongoing with regard to the other involved factors, especially in younger patients. This study aimed to evaluate...

Cite
Soare I, Sirbu A, Diculescu MM, et al. Lean mass, magnesium, faecal calprotectin and glucocorticoid exposure as risk factors for low bone mineral density in inflammatory bowel disease patients. Endocr Connect. 2021;10(8):918-925doi: 10.1530/EC-21-0138.
Soare, I., Sirbu, A., Diculescu, M. M., Mateescu, B. R., Tieranu, C., Martin, S., Barbu, C. G., Ionescu, M., & Fica, S. (2021). Lean mass, magnesium, faecal calprotectin and glucocorticoid exposure as risk factors for low bone mineral density in inflammatory bowel disease patients. Endocrine connections, 10(8), 918-925. https://doi.org/10.1530/EC-21-0138
Soare, Iulia, et al. "Lean mass, magnesium, faecal calprotectin and glucocorticoid exposure as risk factors for low bone mineral density in inflammatory bowel disease patients." Endocrine connections vol. 10,8 (2021): 918-925. doi: https://doi.org/10.1530/EC-21-0138
Soare I, Sirbu A, Diculescu MM, Mateescu BR, Tieranu C, Martin S, Barbu CG, Ionescu M, Fica S. Lean mass, magnesium, faecal calprotectin and glucocorticoid exposure as risk factors for low bone mineral density in inflammatory bowel disease patients. Endocr Connect. 2021 Aug 09;10(8):918-925. doi: 10.1530/EC-21-0138. PMID: 34261042; PMCID: PMC8428027.
Copy Download .nbib Format: NLM
EUS-guided transgastric pancreatic necrosectomy in a patient with sleeve gastrectomy (with video).

Endoscopic ultrasound

Sisman G, Barbur E, Saka D, Piyade B, Boynukara C.
PMID: 33463557
Endosc Ultrasound. 2021 Nov-Dec;10(6):474-475. doi: 10.4103/EUS-D-20-00152.

No abstract available.

Cite
Sisman G, Barbur E, Saka D, et al. EUS-guided transgastric pancreatic necrosectomy in a patient with sleeve gastrectomy (with video). Endosc Ultrasound. 2021;10(6):474-475doi: 10.4103/EUS-D-20-00152.
Sisman, G., Barbur, E., Saka, D., Piyade, B., & Boynukara, C. (2021). EUS-guided transgastric pancreatic necrosectomy in a patient with sleeve gastrectomy (with video). Endoscopic ultrasound, 10(6), 474-475. https://doi.org/10.4103/EUS-D-20-00152
Sisman, Gurhan, et al. "EUS-guided transgastric pancreatic necrosectomy in a patient with sleeve gastrectomy (with video)." Endoscopic ultrasound vol. 10,6 (2021): 474-475. doi: https://doi.org/10.4103/EUS-D-20-00152
Sisman G, Barbur E, Saka D, Piyade B, Boynukara C. EUS-guided transgastric pancreatic necrosectomy in a patient with sleeve gastrectomy (with video). Endosc Ultrasound. 2021 Nov-Dec;10(6):474-475. doi: 10.4103/EUS-D-20-00152. PMID: 33463557.
Copy Download .nbib Format: NLM
Using the needs of WHO to prioritise Cochrane reviews: The case of antipsychotic drugs.

International journal of mental health systems

Purgato M, Barbui C, Adams CE.
PMID: 21943196
Int J Ment Health Syst. 2011 Sep 24;5:25. doi: 10.1186/1752-4458-5-25.

BACKGROUND: This study aimed to investigate existing trialling activity relating to three antipsychotic drugs from the WHO List of Essential Medicines (chlorpromazine, fluphenazine decanoate, haloperidol), link existing trials to existing Cochrane reviews, identify gaps in reviewing activity on accessible...

Cite
Purgato M, Barbui C, Adams CE. Using the needs of WHO to prioritise Cochrane reviews: The case of antipsychotic drugs. Int J Ment Health Syst. 2011;5:25doi: 10.1186/1752-4458-5-25.
Purgato, M., Barbui, C., & Adams, C. E. (2011). Using the needs of WHO to prioritise Cochrane reviews: The case of antipsychotic drugs. International journal of mental health systems, 525. https://doi.org/10.1186/1752-4458-5-25
Purgato, Marianna, et al. "Using the needs of WHO to prioritise Cochrane reviews: The case of antipsychotic drugs." International journal of mental health systems vol. 5 (2011): 25. doi: https://doi.org/10.1186/1752-4458-5-25
Purgato M, Barbui C, Adams CE. Using the needs of WHO to prioritise Cochrane reviews: The case of antipsychotic drugs. Int J Ment Health Syst. 2011 Sep 24;5:25. doi: 10.1186/1752-4458-5-25. PMID: 21943196; PMCID: PMC3204288.
Copy Download .nbib Format: NLM
Showing 241 to 251 of 251 entries